A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies (CaDAnCe-101)
NCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 06188520 Brief Summary This study is designed to evaluate AZD8421…
Read more arrow_forwardNCT 05858164 Brief Summary Researchers are looking for a better way…
Read more arrow_forwardNCT 05984277 Brief Summary The purpose of eVOLVE-Lung02 is to test…
Read more arrow_forwardNCT 05221840 Brief Summary This is a Phase III, randomised, double-blind,…
Read more arrow_forwardNCT 05999994 Brief Summary The main purpose of the master is to…
Read more arrow_forwardNCT 06170190 Brief Summary This is a multicentre, open-label, first-in-human, phase 1/2…
Read more arrow_forwardNCT 04735575 Brief Summary The primary purpose of this study is to…
Read more arrow_forwardNCT 03746431 Brief Summary This is a first-in-human Phase 1/2, non-randomized,…
Read more arrow_forwardNCT 05304377 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forward